Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants.
Saved in:
| Title: | Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants. |
|---|---|
| Authors: | Hsu CH; AP Biosciences Inc., Taipei, Taiwan., Chang TY; AP Biosciences Inc., Taipei, Taiwan., Chang YM; AP Biosciences Inc., Taipei, Taiwan., Lin SH; AP Biosciences Inc., Taipei, Taiwan., Chen TN; AP Biosciences Inc., Taipei, Taiwan., Hsu KH; AP Biosciences Inc., Taipei, Taiwan., You JJ; AP Biosciences Inc., Taipei, Taiwan. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 17; Vol. 17, pp. 1793368. Date of Electronic Publication: 2026 Jun 17 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1793368 |
